Reducing Effect of IL-32α in the Development of Stroke Through Blocking of NF-κB, but Enhancement of STAT3 Pathways

[1]  E. Isenovic,et al.  Link Between Oxidative Stress and Acute Brain Ischemia , 2014, Angiology.

[2]  A. Nadeem,et al.  Glutathione modulation during sensitization as well as challenge phase regulates airway reactivity and inflammation in mouse model of allergic asthma. , 2014, Biochimie.

[3]  F. Liu,et al.  Propofol Protects Against Focal Cerebral Ischemia via Inhibition of Microglia-Mediated Proinflammatory Cytokines in a Rat Model of Experimental Stroke , 2013, PloS one.

[4]  G. Marsicano,et al.  Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats , 2013, Brain Research.

[5]  Chunhua Zhu,et al.  Parthenolide Is Neuroprotective in Rat Experimental Stroke Model: Downregulating NF-κB, Phospho-p38MAPK, and Caspase-1 and Ameliorating BBB Permeability , 2013, Mediators of inflammation.

[6]  Jiumao Lin,et al.  Electroacupuncture ameliorates cognitive impairment through inhibition of NF-κB-mediated neuronal cell apoptosis in cerebral ischemia-reperfusion injured rats. , 2013, Molecular medicine reports.

[7]  G. Hu,et al.  Paeoniflorin Protects against Ischemia-Induced Brain Damages in Rats via Inhibiting MAPKs/NF-κB-Mediated Inflammatory Responses , 2012, PloS one.

[8]  H. Qiao,et al.  Protective Effect of Luteolin in Experimental Ischemic Stroke: Upregulated SOD1, CAT, Bcl-2 and Claudin-5, Down-Regulated MDA and Bax Expression , 2012, Neurochemical Research.

[9]  F. Islam,et al.  Piperine suppresses cerebral ischemia–reperfusion-induced inflammation through the repression of COX-2, NOS-2, and NF-κB in middle cerebral artery occlusion rat model , 2012, Molecular and Cellular Biochemistry.

[10]  R. Sultana,et al.  Sex differences in brain proteomes of neuron‐specific STAT3‐null mice after cerebral ischemia/reperfusion , 2012, Journal of neurochemistry.

[11]  L. Xiong,et al.  Electroacupuncture Pretreatment as a Novel Avenue to Protect Brain against Ischemia and Reperfusion Injury , 2012, Evidence-based complementary and alternative medicine : eCAM.

[12]  Xiaoling Zhang,et al.  Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia , 2012, Brain Research.

[13]  Gelin Xu,et al.  Suppression of local inflammation contributes to the neuroprotective effect of ginsenoside Rb1 in rats with cerebral ischemia , 2012, Neuroscience.

[14]  M. Beal,et al.  Neuroprotective strategies involving ROS in Alzheimer disease. , 2011, Free radical biology & medicine.

[15]  R. Giffard,et al.  Astrocytes: targets for neuroprotection in stroke. , 2011, Central nervous system agents in medicinal chemistry.

[16]  L. Xiong,et al.  Reactive Oxygen Species Scavenger Inhibits STAT3 Activation After Transient Focal Cerebral Ischemia–Reperfusion Injury in Rats , 2011, Anesthesia and analgesia.

[17]  H. J. Kim,et al.  IL-32γ inhibits cancer cell growth through inactivation of NF-κB and STAT3 signals , 2011, Oncogene.

[18]  R. Veerhuis.  Histological and direct evidence for the role of complement in the neuroinflammation of AD. , 2011, Current Alzheimer research.

[19]  C. Dinarello,et al.  Paradoxical effects of constitutive human IL-32γ in transgenic mice during experimental colitis , 2010, Proceedings of the National Academy of Sciences.

[20]  C. Rosen,et al.  Age exaggerates proinflammatory cytokine signaling and truncates signal transducers and activators of transcription 3 signaling following ischemic stroke in the rat , 2010, Neuroscience.

[21]  Wei Du,et al.  Baicalein is neuroprotective in rat MCAO model: Role of 12/15-lipoxygenase, mitogen-activated protein kinase and cytosolic phospholipase A2 , 2010, Pharmacology Biochemistry and Behavior.

[22]  G. Perry,et al.  Oxidative stress in Alzheimer disease: A possibility for prevention , 2010, Neuropharmacology.

[23]  Wei Du,et al.  Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-κB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia , 2010, Brain Research.

[24]  L. Edvinsson,et al.  Cerebral ischemia induces microvascular pro-inflammatory cytokine expression via the MEK/ERK pathway , 2010, Journal of Neuroinflammation.

[25]  V. Echeverria,et al.  Sorafenib inhibits nuclear factor kappa B, decreases inducible nitric oxide synthase and cyclooxygenase-2 expression, and restores working memory in APPswe mice , 2009, Neuroscience.

[26]  C. Kaltschmidt,et al.  NF-kappaB in the nervous system. , 2009, Cold Spring Harbor perspectives in biology.

[27]  D. Yoon,et al.  A proinflammatory cytokine interleukin‐32β promotes the production of an anti‐inflammatory cytokine interleukin‐10 , 2009, Immunology.

[28]  P. Vallet,et al.  In vivo over‐expression of interleukin‐10 increases resistance to focal brain ischemia in mice , 2009, Journal of neurochemistry.

[29]  Y. Liu,et al.  Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-κB expression , 2009, Brain Research.

[30]  Jongheop Yi,et al.  Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. , 2008, Toxicology letters.

[31]  Peng Huang,et al.  Redox regulation of cell survival. , 2008, Antioxidants & redox signaling.

[32]  S. Campbell,et al.  Hepatic Nuclear Factor &kgr;B Regulates Neutrophil Recruitment to the Injured Brain , 2008, Journal of neuropathology and experimental neurology.

[33]  Z. Qin,et al.  Dual roles of NF-κB in cell survival and implications of NF-κB inhibitors in neuroprotective therapy , 2007, Acta Pharmacologica Sinica.

[34]  S. Gerondakis,et al.  Tissue-specific effects of the nuclear factor kappaB subunit p50 on myocardial ischemia-reperfusion injury. , 2007, The American journal of pathology.

[35]  O. Rønnekleiv,et al.  Role of Signal Transducer and Activator of Transcription-3 in Estradiol-Mediated Neuroprotection , 2007, The Journal of Neuroscience.

[36]  N. Patel,et al.  Inhibition of Aβ production by NF-κB inhibitors , 2007, Neuroscience Letters.

[37]  M. Mattson,et al.  NF-κB as a therapeutic target in neurodegenerative diseases , 2007 .

[38]  Á. Chamorro,et al.  Signalling pathways mediating inflammatory responses in brain ischaemia. , 2006, Biochemical Society transactions.

[39]  A. Geronikaki,et al.  Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. , 2006, Combinatorial chemistry & high throughput screening.

[40]  David S. Park,et al.  NFκB in neurons? The Uncertainty Principle in neurobiology , 2006 .

[41]  M. Netea,et al.  IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Kaltschmidt,et al.  Signaling via NF-?B in the nervous system , 2005 .

[43]  R. Bolli,et al.  Role of the Protein Kinase C-&egr;–Raf-1–MEK-1/2–p44/42 MAPK Signaling Cascade in the Activation of Signal Transducers and Activators of Transcription 1 and 3 and Induction of Cyclooxygenase-2 After Ischemic Preconditioning , 2005, Circulation.

[44]  M. Moskowitz,et al.  Neuroprotection by IL-10-producing MOG CD4+ T cells following ischemic stroke , 2005, Journal of the Neurological Sciences.

[45]  N. Rothwell,et al.  CNS injury: the role of the cytokine IL-1. , 2004, Veterinary journal.

[46]  N. Greig,et al.  Cholesterol and Alzheimer's disease: clinical and experimental models suggest interactions of different genetic, dietary and environmental risk factors. , 2004, Current drug targets.

[47]  C. Sommer,et al.  Effect of Brain-Derived Neurotrophic Factor Treatment and Forced Arm Use on Functional Motor Recovery After Small Cortical Ischemia , 2004, Stroke.

[48]  M. Karjalainen‐Lindsberg,et al.  Nuclear Factor- (cid:1) B Contributes to Infarction After Permanent Focal Ischemia , 2004 .

[49]  Eng H. Lo,et al.  Neurological diseases: Mechanisms, challenges and opportunities in stroke , 2003, Nature Reviews Neuroscience.

[50]  T. Murphy,et al.  Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress , 2003, The Journal of Neuroscience.

[51]  Gert Lubec,et al.  Aberrant expression of peroxiredoxin subtypes in neurodegenerative disorders , 2003, Brain Research.

[52]  B. Yoo,et al.  Expression patterns of antioxidant proteins in brains of patients with sporadic Creutzfeldt‐Jacob disease , 2002, Electrophoresis.

[53]  R. Bolli,et al.  An essential role of the JAK-STAT pathway in ischemic preconditioning , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[54]  P. Chan.  Reactive Oxygen Radicals in Signaling and Damage in the Ischemic Brain , 2001, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[55]  S. Ghosh,et al.  Molecular mechanisms of NF-κB activation induced by bacterial lipopolysaccharide through Toll-like receptors: , 2000 .

[56]  E. Ongini,et al.  Interleukin‐10 modulates neuronal threshold of vulnerability to ischaemic damage , 2000, The European journal of neuroscience.

[57]  C. Justicia,et al.  Activation of the JAK/STAT pathway following transient focal cerebral ischemia: Signaling through Jak1 and Stat3 in astrocytes , 2000, Glia.

[58]  Haruo Okado,et al.  Tumor Necrosis Factor Induces Bcl-2 and Bcl-x Expression through NFκB Activation in Primary Hippocampal Neurons* , 1999, The Journal of Biological Chemistry.

[59]  R. Yezierski,et al.  Traumatic Spinal Cord Injury Induces Nuclear Factor-κB Activation , 1998, The Journal of Neuroscience.

[60]  Ulrich Dirnagl,et al.  Increased Formation of Reactive Oxygen Species after Permanent and Reversible Middle Cerebral Artery Occlusion in the Rat , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[61]  G. Benzi,et al.  Are reactive oxygen species involved in Alzheimer's disease? , 1995, Neurobiology of Aging.

[62]  D. Bredesen,et al.  Bcl-2 inhibition of neural death: decreased generation of reactive oxygen species. , 1993, Science.

[63]  J. Coyle,et al.  Oxidative stress, glutamate, and neurodegenerative disorders. , 1993, Science.

[64]  J. Adams,et al.  Free radical induction in the brain and liver by products of toluene catabolism. , 1993, Biochemical pharmacology.

[65]  S. Arbuck,et al.  Taxol: the first of the taxanes, an important new class of antitumor agents. , 1992, Seminars in oncology.

[66]  E. Hogan,et al.  A model of focal ischemic stroke in the rat: reproducible extensive cortical infarction. , 1986, Stroke.

[67]  Chen Chang,et al.  Stroke, angiogenesis and phytochemicals. , 2012, Frontiers in bioscience.

[68]  N. Alkayed,et al.  Role of Signal Transducer and Activator of Transcription 3 in Neuronal Survival and Regeneration , 2008, Reviews in the neurosciences.

[69]  N. Patel,et al.  Inhibition of Abeta production by NF-kappaB inhibitors. , 2007, Neuroscience letters.

[70]  M. Mattson,et al.  NF-kappa B as a therapeutic target in neurodegenerative diseases. , 2007, Expert opinion on therapeutic targets.

[71]  Z. Qin,et al.  Dual roles of NF-kappaB in cell survival and implications of NF-kappaB inhibitors in neuroprotective therapy. , 2007, Acta pharmacologica Sinica.

[72]  David S. Park,et al.  NFkappaB in neurons? The uncertainty principle in neurobiology. , 2006, Journal of neurochemistry.

[73]  D. Yoon,et al.  Interleukin-32: a cytokine and inducer of TNFalpha. , 2005, Immunity.

[74]  C. Kaltschmidt,et al.  Signaling via NF-kappaB in the nervous system. , 2005, Biochimica et biophysica acta.

[75]  C. Roussos,et al.  Production of interleukin-6 by skeletal myotubes: role of reactive oxygen species. , 2002, American journal of respiratory cell and molecular biology.

[76]  A. Martin-Villalba,et al.  NF-kappaB is activated and promotes cell death in focal cerebral ischemia. , 1999, Nature medicine.

[77]  R. Yezierski,et al.  Traumatic spinal cord injury induces nuclear factor-kappaB activation. , 1998, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[78]  E. Hall,et al.  Central nervous system trauma and stroke. II. Physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. , 1989, Free radical biology & medicine.

[79]  P. Weinstein,et al.  Reversible middle cerebral artery occlusion without craniectomy in rats. , 1989, Stroke.